- $30.64m
- $21.05m
- $10.55m
Brief: United Guardian receives FDA approval to market new form of Renacidin
Brief: United Guardian says receives FDA approval to market new single-dose form of Renacidin
Brief: United Guardian Q3 earnings per share $0.26
Brief: United Guardian announces increase in mid-year dividend
Brief: United Guardian Q1 earnings per share $0.32